Portfolio company
Hemosphere
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops vascular access devices for dialysis patients with end-stage renal disease and compromised vasculature to facilitate treatment and reduce infection risks.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Home Dialysis Plus
This company develops portable hemodialysis systems for patients with end-stage renal disease to use in home and clinical environments.
XS Innovations
This company develops implantable vascular access valves for patients with end-stage kidney disease to reduce complications during and between haemodialysis sessions.
ENDOVASCULAR DEVICES
This company develops minimally invasive vessel preparation tools to treat peripheral artery disease and failed arteriovenous fistulas for interventional clinicians.
VenoStent
This company develops bioabsorbable vascular wraps for chronic kidney disease patients to improve the durability and success of haemodialysis access sites.
Proteon Therapeutics
This company develops pharmaceuticals to improve blood flow and vascular access for patients with kidney and vascular diseases.
Laminate Medical Technologies
This company develops an external support device to improve fistula success for hospitals and clinicians treating patients requiring dialysis.
Healionics
Healionics produces synthetic vascular grafts for dialysis patients to improve blood access and reduce complications such as infection and occlusion.
VASCULAR THERAPIES
This biotechnology company develops biodegradable collagen implants delivering sirolimus to improve vascular access outcomes for patients with kidney and vascular disease.
